Prostate Cancer

James Knight, MD, discusses a case study of a patient with brain-metastatic prostate adenocarcinoma.

Emmanuel Antonarakis, MD, discusses community enrollment in the ECLIPSE trial in prostate cancer.

Gautam Jha, MD, and Emmanuel Antonarakis, MD, on the advantages of collaborative efforts between community and academic oncologists.

Minesh Mehta, MD, discusses recent advancements in radiation oncology approaches for patients with prostate cancer.

Minesh Mehta, MD, discusses how MRI-guided adaptive radiation therapy systems may improve disease outcomes in cancer care.

Ruben Olivares, MD, discusses the evolving role for focal radiation therapy in the management of prostate cancer.

Neeraj Agarwal, MD, FASCO, discusses unmet needs across the prostate cancer spectrum and ongoing trials investigating agents in earlier settings.

Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.

Daniel Spratt, MD, discusses the integration of metastasis-directed therapy and hypofractionation in prostate cancer.

Robert Dreicer, MD, discusses the complex landscape of prostate cancer treatment, highlighting key points from his presentation at the 2024 NY GU.

Mary-Ellen Taplin, MD, discusses ways to mitigate health care disparities in the treatment of patients with prostate cancer.

Daniel Spratt, MD, discusses the use of radiation therapy in low- and high-risk prostate cancer.

Philip J. Koo, MD, discusses the treatment of patients with prostate cancer throughout the different stages of their disease.

The EMA’s CHMP has recommended the approval of enzalutamide with or without androgen deprivation therapy in biochemically recurrent nmHSPC.

Anthony V. D'Amico, MD, PhD, on the advancements in high-risk prostate cancer diagnosis and management

Shanta Dhar, PhD, FRSC, discusses the significance of being named a fellow of the National Academy of Inventors for her research in prostate cancer.

Mary-Ellen Taplin, MD, discusses strategies to mitigate health care inequities in prostate cancer.

Emmanuel Antonarakis, MD, discusses the significance of TALPRO-3, EVOPAR, and AMPLITUDE trials on the metastatic prostate cancer treatment paradigm.

Mary-Ellen Taplin, MD, discusses efforts to address disparities in access to, and delivery of, prostate cancer care.

James Knight, MD, discusses the potential launch of a case series of patients with brain-metastatic prostate adenocarcinoma.

Oliver Sartor, MD, discusses the use of PSMA PET and radioligand therapy in prostate cancer.

Oliver Sartor, MD, discusses ongoing prostate cancer research, highlighting the importance of considering patient quality of life.

Jeremie Calais, MD, PhD, discusses controversies and unresolved questions in the treatment of patients with prostate cancer.

Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management.

Neeraj Agarwal, FASCO, MD, discusses quality of life considerations for patients with prostate cancer.